Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...
Sortiert nach
    Datensatz exportieren als...
  • BibTeX
Multicenter randomized‐controlled clinical trial of probiotics (Lactobacillus johnsonii, LA1) on early endoscopic recurrence of Crohn's disease after ileo‐caecal resection
Inflammatory bowel diseases, 2007-02, Vol.13 (2), p.135-142
2007
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
S734 IBD Patients’ Treatment Preferences Are Heterogeneous, but Largely Affected by the Avoidance of Abdominal Pain and Side Effects (P-POWER IBD Study)
The American journal of gastroenterology, 2021-10, Vol.116 (1), p.S337-S337
2021
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
S0643 Composite and Individual Measures of Efficacy and Safety of Upadacitinib Treatment for Crohn's Disease: 12-Month Results From the Ongoing Phase 2 CELEST Open-Label Extension Study
The American journal of gastroenterology, 2020-10, Vol.115 (1), p.S322-S323
2020
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
S943 Analysis of International Spontaneous Reporting System Databases for Safety of Corticosteroids in Inflammatory Bowel Disease: The Determinants, Incidence and Consequences of Corticosteroid Excess (DICE)-Impact Study
The American journal of gastroenterology, 2021-10, Vol.116 (1), p.S448-S449
2021
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
The Real World Global Use of Patient-Reported Outcomes (PROs) for the Care of Patients With IBD
The American journal of gastroenterology, 2022, Vol.117 (10 Suppl.), p.S704
2022
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
S822 Fatigue Improvement Correlates With Reductions in Work Productivity Impairment and Related Indirect Cost in Patients With Crohn’s Disease: Post Hoc Analysis of Phase 3 Rizankizumab Induction Trials
The American journal of gastroenterology, 2022-10, Vol.117 (10S), p.e591-e592
2022
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
S713 Induction and Maintenance Treatment with Risankizumab Leads to Symptomatic Relief in Patients With Moderate to Severe Crohn’s Disease
The American journal of gastroenterology, 2022-10, Vol.117 (10S), p.e496-e497
2022
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
S4 Risankizumab Induction Therapy in Patients With Moderately to Severely Active Ulcerative Colitis: Efficacy and Safety in the Randomized Phase 3 INSPIRE Study
The American journal of gastroenterology, 2023-12, Vol.118 (12S), p.S2-S2
2023
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
S845 Risankizumab Induction Therapy in Patients With Moderately to Severely Active Ulcerative Colitis: Efficacy and Safety in the Randomized Phase 3 INSPIRE Study
The American journal of gastroenterology, 2023-10, Vol.118 (10S), p.S624-S625
2023
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
S737 Effect of Risankizumab on Patient-Reported Outcomes in Patients With Crohn’s Disease With Inadequate Response or Intolerance to Conventional And/or Biologic Treatments: Results From Phase 3 MOTIVATE and ADVANCE Trials
The American journal of gastroenterology, 2021-10, Vol.116 (1), p.S338-S338
2021
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
S37 Efficacy and Safety of Upadacitinib Maintenance Therapy in Patients With Moderately to Severely Active Crohn’s Disease: U-ENDURE Phase 3 Results
The American journal of gastroenterology, 2022-12, Vol.117 (12S), p.S10-S10
2022
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
An Analysis of Latest Data on Sequential Use of Biologic Therapies in Patients with Inflammatory Bowel Disorder: A Systematic Literature Review: 715
The American journal of gastroenterology, 2018-10, Vol.113 (Supplement), p.S401-S402
2018
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
S972 The Real World Global Use of Patient-Reported Outcomes (PROs) for the Care of Patients With IBD
The American journal of gastroenterology, 2022-10, Vol.117 (10S), p.e704-e705
2022
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
806 Long-Term Safety and Efficacy of Risankizumab Treatment in Patients With Crohn’s Disease: 3-Year Interim Results From the Ongoing Phase 2 Open-Label Extension Study
The American journal of gastroenterology, 2019-10, Vol.114 (1), p.S466-S466
2019
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
S0815 Effect of Mirikizumab on Inflammatory Biomarkers in a Phase 2 Study of Patients With Crohn’s Disease
The American journal of gastroenterology, 2020-10, Vol.115 (1), p.S418-S419
2020
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
S736 Efficacy and Safety of Upadacitinib Induction Therapy in Patients With Moderately to Severely Active Crohn’s Disease: Results From a Randomized Phase 3 U-EXCEL Study
The American journal of gastroenterology, 2022-10, Vol.117 (10S), p.e518-e518
2022
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
S789 Effect of Mirikizumab on Inflammatory Biomarkers in a Phase 2 Study of Patients With Crohn’s Disease
The American journal of gastroenterology, 2021-10, Vol.116 (1), p.S367-S367
2021
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
672 Defining Meaningful Attributes for the Treatment of IBD From Patients' Perspective
The American journal of gastroenterology, 2019-10, Vol.114 (1), p.S395-S395
2019
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
834 Early Symptom Improvement With Risankizumab Treatment in Patients With Moderately to Severely Active Crohn’s Disease: Analysis From a Phase 2 Study
The American journal of gastroenterology, 2019-10, Vol.114 (1), p.S482-S482
2019
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
S0881 Therapeutic Drug Monitoring Dosing Regimen With Adalimumab in Patients With Moderately to Severely Active Ulcerative Colitis: Results From the SERENE-UC Maintenance Study
The American journal of gastroenterology, 2020-10, Vol.115 (1), p.S454-S454
2020
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
S0648 Clinically Adjusted vs Therapeutic Drug Monitoring Dosing Regimens With Adalimumab in Patients With Moderately to Severely Active Crohn's Disease: Results From the SERENE-CD Maintenance Study
The American journal of gastroenterology, 2020-10, Vol.115 (1), p.S325-S326
2020
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Therapeutic Targeting of Specific Populations (Pharmacogenetics)
Inflammatory bowel diseases, 2006-04, Vol.12, p.S15
2006
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
Assessment of endoscopic activity index and biological inflammatory markers in clinically active Crohn's disease with normal C‐reactive protein serum level
Inflammatory bowel diseases, 2007-09, Vol.13 (9), p.1100-1105
2007
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
P037 LONG-TERM SAFETY, EFFICACY AND PHARMACOKINETICS OF THE ANTI-MUCOSAL ADDRESSIN CELL ADHESION MOLECULE-1 (MADCAM-1) MONOCLONAL ANTIBODY SHP647 IN CROHN’S DISEASE: THE OPERA II STUDY
Inflammatory bowel diseases, 2019-02, Vol.25 (Supplement_1), p.S18-S19
2019
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Sustained Resolution of Extraintestinal Manifestations in Patients with Crohnʼs Disease Receiving Adalimumab: 670
The American journal of gastroenterology, 2016-10, Vol.111, p.S305
2016
Volltextzugriff (PDF)
1 – 25 von 63
Suche als RSS-Feed
Aktive Filter
ThemaLife Sciences & Biomedicine
ThemaPhysical Sciences
KollektionWiley Online Library Journals Frontfile Complete
Suchergebnisse filtern
Filter anzeigen